Clinical trial
Effect of Roflumilast on Airway Blood Flow as an Expression of Airway Inflammation in COPD
NCT02097992 is registered in ClinicalTrials.gov with University of Miami as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Roflumilast on Airway Blood Flow as an Expression of Airway Inflammation in COPD
- Lead sponsor
- University of Miami
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- February 28, 2013
- Completion date
- July 31, 2015
- Enrollment
- 11 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
copd